V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20195593 | 20124922 | 1.8 | 91.8 | Palliative (P) | 2018-06-28 | 2018-09-27 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100137249 |
| 20195595 | 20124923 | 1.74 | 69 | Palliative (P) | 2018-05-25 | 2018-07-05 | CETUXIMAB | 02 | N | TRASTUZUMAB | 101781685 |
| 20195601 | 20124924 | 1.8 | 67.2 | Palliative (P) | 2016-04-19 | 2016-05-02 | CETUXIMAB | N | N | CETUXIMAB | 101737317 |
| 20195603 | 20124925 | 1.87 | 64.1 | Palliative (P) | null | 2018-10-17 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 100673914 |
| 20195605 | 20124926 | 1.72 | 47.8 | Adjuvant (A) | 2019-12-01 | 2019-12-23 | CETUXIMAB | 02 | N | TRASTUZUMAB | 101794216 |
| 20195614 | 20124927 | 1.72 | 68.3 | Palliative (P) | 2020-05-05 | 2020-05-24 | Trastuzumab 21 day maintenance | 02 | Y | TRASTUZUMAB | 101680082 |
| 20195616 | 20124928 | 1.82 | 84.4 | null | 2018-01-06 | 2018-01-06 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 100178643 |
| 20195619 | 20124929 | 1.75 | 89.2 | Palliative (P) | 2015-08-17 | 2017-02-09 | CETUXIMAB | 02 | N | CETUXIMAB | 100999196 |
| 20195623 | 20124930 | 1.61 | 70.7 | Palliative (P) | 2020-01-17 | 2020-02-08 | CETUXIMAB | N | N | CAPECITABINE + CISPLATIN | 100191321 |
| 20195624 | 20124931 | 1.8 | 73 | null | 2019-01-18 | 2019-02-02 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN | 100928441 |
| 20195626 | 20124932 | 1.51 | 65 | Palliative (P) | 2016-08-24 | 2016-11-13 | CETUXIMAB | 02 | N | CETUXIMAB | 101711587 |
| 20195629 | 20124933 | 1.65 | 66.2 | Adjuvant (A) | 2013-08-23 | 2016-09-01 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101525021 |
| 20195634 | 20124934 | 1.8 | 54.8 | null | 2017-05-24 | 2017-05-25 | CETUXIMAB | 02 | N | TRASTUZUMAB | 100713407 |
| 20195640 | 20124935 | 1.7 | 40.6 | Adjuvant (A) | null | 2018-12-12 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100028895 |
| 20195644 | 20124936 | 1.76 | 85.6 | Palliative (P) | 2016-12-25 | 2017-01-10 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101010173 |
| 20195645 | 20124937 | 1.7 | 60.4 | Adjuvant (A) | 2019-03-25 | 2019-04-10 | CETUXIMAB | 02 | N | CETUXIMAB | 100741823 |
| 20195647 | 20124938 | 1.76 | 80.75 | Palliative (P) | 2018-07-12 | 2018-08-25 | Cetuximab 14 day | N | N | CETUXIMAB | 101383999 |
| 20195648 | 20124939 | 1.52 | 70 | Adjuvant (A) | 2019-10-29 | 2019-10-29 | TRASTUZUMAB | 02 | N | CETUXIMAB | 101506317 |
| 20195649 | 20124940 | 1.76 | 65.05 | Adjuvant (A) | 2017-11-09 | 2018-03-05 | CETUXIMAB | 02 | Y | CETUXIMAB | 100575086 |
| 20195656 | 20124941 | 1.57 | 51 | Palliative (P) | 2014-08-31 | 2016-02-23 | Capecitabine + Cisplatin + RT | 02 | Y | CAPECITABINE + CISPLATIN | 100383244 |
| 20195661 | 20124942 | 1.72 | 102 | null | 2019-02-06 | 2019-02-09 | Cetuximab 14 day | 02 | null | CETUXIMAB | 101392234 |
| 20195663 | 20124943 | 1.72 | 106.6 | null | 2017-10-10 | 2017-10-22 | Cetuximab 14 day | 02 | null | CETUXIMAB | 100522660 |
| 20195665 | 20124944 | 1.8 | 59.8 | Adjuvant (A) | 2016-03-26 | 2016-03-26 | Trastuzumab | 02 | N | TRASTUZUMAB | 100183864 |
| 20195670 | 20124945 | 1.61 | 78.15 | Neo-adjuvant (N) | 2016-10-25 | 2016-11-22 | CETUXIMAB | N | N | CETUXIMAB | 100143079 |
| 20195671 | 20124946 | 1.73 | 80.7 | Curative (C) | 2017-08-18 | 2017-08-18 | Cetuximab 14 day | 2 | null | CETUXIMAB | 100676871 |
| 20195680 | 20124947 | 1.59 | 93 | Not known (9) | 2018-04-06 | 2018-04-30 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 100967817 |
| 20195681 | 20124948 | 1.74 | 108 | Curative (C) | 2017-09-27 | 2017-10-05 | CETUXIMAB | N | N | CETUXIMAB | 100895369 |
| 20195683 | 20124949 | 1.82 | 49 | Neo-adjuvant (N) | 2017-08-07 | 2017-08-07 | CETUXIMAB | 02 | N | TRASTUZUMAB | 100675170 |
| 20195696 | 20124950 | 1.81 | 133 | null | 2018-10-05 | 2018-10-19 | CETUXIMAB | 02 | null | CETUXIMAB | 100240086 |
| 20195697 | 20124951 | 1.58 | 45.55 | Palliative (P) | 2018-08-27 | 2018-09-09 | Trastuzumab | 02 | N | TRASTUZUMAB | 101214339 |
| 20195698 | 20124952 | null | null | Palliative (P) | 2017-10-04 | 2017-10-04 | Capecitabine + Cisplatin | 02 | Y | CAPECITABINE + CISPLATIN | 100138381 |
| 20195700 | 20124953 | 1.76 | 73 | Palliative (P) | null | 2017-05-15 | Trastuzumab | 02 | N | TRASTUZUMAB | 100573397 |
| 20195706 | 20124954 | 1.65 | 75.3 | Palliative (P) | 2019-05-31 | 2019-06-06 | CETUXIMAB | 02 | N | TRASTUZUMAB | 101306688 |
| 20195710 | 20124955 | 1.72 | 68.1 | Palliative (P) | 2016-06-02 | 2017-04-05 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101548140 |
| 20195711 | 20124956 | 1.7 | 75 | Palliative (P) | 2017-06-08 | 2017-06-12 | Capecitabine + Cisplatin | N | N | CETUXIMAB | 100522954 |
| 20195712 | 20124957 | 1.7 | 53 | null | 2018-10-17 | 2018-11-24 | CETUXIMAB | 02 | null | CETUXIMAB | 101486024 |
| 20195713 | 20124958 | 1.83 | 43.8 | Palliative (P) | 2016-11-21 | 2017-08-05 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101442321 |
| 20195717 | 20124959 | 1.77 | 74 | Curative (C) | 2018-08-26 | 2018-09-11 | Trastuzumab | 02 | Y | TRASTUZUMAB | 100455238 |
| 20195719 | 20124960 | 1.69 | 67.2 | Palliative (P) | 2020-02-26 | 2020-03-12 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101388511 |
| 20195724 | 20124961 | 1.74 | 81.2 | null | 2019-08-20 | 2019-08-27 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101397625 |
| 20195731 | 20124962 | 1.66 | 84.1 | Adjuvant (A) | 2018-07-02 | 2018-07-05 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100218176 |
| 20195737 | 20124963 | 1.84 | 43.45 | Curative (C) | 2019-05-04 | 2019-05-05 | Trastuzumab | 02 | N | TRASTUZUMAB | 100314138 |
| 20195740 | 20124964 | 1.77 | 69 | Adjuvant (A) | 2016-06-29 | 2016-10-01 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 100235697 |
| 20195741 | 20124965 | 1.54 | 75 | Adjuvant (A) | 2019-03-04 | 2019-03-25 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101566262 |
| 20195748 | 20124966 | 1.8 | 75 | 03 | 2016-11-24 | 2016-12-17 | CETUXIMAB | null | N | CETUXIMAB | 100364657 |
| 20195752 | 20124967 | 1.57 | 77.1 | Adjuvant (A) | 2019-06-12 | 2019-06-13 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101735985 |
| 20195754 | 20124968 | 1.62 | 71.4 | Palliative (P) | 2017-02-08 | 2017-03-06 | Capecitabine + Cisplatin | N | null | CAPECITABINE + CISPLATIN | 100463423 |
| 20195755 | 20124969 | 1.65 | 76.7 | Adjuvant (A) | 2019-12-20 | 2020-01-02 | Capecitabine + Cisplatin | 2 | N | CAPECITABINE + CISPLATIN | 100209542 |
| 20195760 | 20124970 | 1.5 | 75 | Palliative (P) | 2017-10-31 | 2017-11-28 | CETUXIMAB | 02 | N | CETUXIMAB | 101091364 |
| 20195762 | 20124971 | 1.66 | 64.45 | Palliative (P) | 2018-05-19 | 2018-05-27 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101439857 |